Studies with iontophoretic administration of drugs to human dermal vessels in vivo: Cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide

British Journal of Clinical Pharmacology

Volumn 45, Issue 6, 1998, Pages 545-550

  Noon, Joseph P ^a,b   Walker, Brian R ^a   Hand, Malcolm F ^a   Webb, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Acetylcholine; Aspirin; Endothelium; Iontophoresis; L N(G) monomethylarginine; Prostacyclin

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PROSTANOID;

ADULT; ARM BLOOD FLOW; ARTICLE; DISEASE ASSOCIATION; DRUG INFUSION; ENDOTHELIUM INJURY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ACETYLCHOLINE; ADULT; ASPIRIN; ENZYME INHIBITORS; HUMANS; IONTOPHORESIS; MALE; NITRIC OXIDE; NITROPRUSSIDE; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; PROSTAGLANDINS; SKIN; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0031812118     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00718.x     Document Type: Article

References (27)

1. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
2. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; ii: 997-1000.
3. Zellers TM, McCormick J, Wu Y. Interaction among ET-1, endothelium-derived nitric oxide, and prostacyclin in pulmonary arteries and veins. Am J Physiol 1994; 267: H139-H147.
4. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarisation: a role in the control of vascular tone. Trends Pharmacol Sci 1995; 16: 23-30.
5. 2 in isolated rat glomeruli. Am J Physiol 1982; 243: F276-F283.
6. Ito S, Carretero OA, Abe K, Beierwaltes WH, Yoshanaga K. Effects of prostanoids on renin release from rabbit afferent arterioles with and without macula densa. Kidney Intl 1989; 35: 1138-1144.
7. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of human forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340: 1430-1432.
8. Linder L, Kiowski W, Buhler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation 1990; 81: 1762-1767.
9. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
10. Treasure CB, Klein JL, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93.
11. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10: 1025-1031.
12. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Circulation 1993; 87: 1468-1474.
13. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilatation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929-933.
14. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036-1040.
15. Westerman RA, Widdop RE, Hannaford J, et al. Laser Doppler fluximetry in the measurement of neurovascular function. Australasian Physical and Engineering Sciences in Medicine 1988; 11: 53-66.
16. Westerman RA, Low AM, Widdop RE, Neild TO, Delaney CA. Non-invasive tests of neurovascular function in human and experimental diabetes mellitus: In Endothelial cell function in diabetic microangiopathy: problems in methodology and clinical aspects, Front Diabetes, Basel: Karger 1990; 9: 127-138.
17. Morris SJ, Shore AC. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: Possible mechanisms. J Physiol 1996, 496: 531-542.
18. Webb DJ. The pharmacology of human blood vessels in vivo. J Vasc Res 1995; 32: 2-15.
19. Noon JP, Haynes WG, Webb DJ, Shore AC. Local inhibition of nitric oxide generation in man reduces blood flow in the finger pulp but not in hand dorsum. J Physiol 1996; 490: 501-508.
20. Walker BR, Connacher AA, Webb DJ, Edwards CRW. Glucocorticoids and blood pressure: a role for the cortisol/ cortisone shuttle in the control of vascular tone in man. Clin Sci 1992; 83: 171-178.
21. Gardner-Medwin JM, Taylor JY, Macdonald IA, Powell RJ. An investigation into variability in microvascular skin blood flow and the responses to transdermal delivery of acetylcholine at different sites in the forearm and hand. Br J Clin Pharmacol 1997, 43: 391-397.
22. Low A, Westerman RA. Neurogenic vasodilation in the rat hairy skin measured using a laser Doppler flowmeter. Life Sci 1989; 45: 49-57.
23. Noon JP, Evans CE, Haynes WG, Webb DJ, Walker BR. A comparison of techniques to assess skin blanching following topical application of glucocorticoids. Br J Dermatol 1996b; 134: 837-842.
24. Heavey DJ, Barrow SE, Hickling NE, Ritter JM. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature 1985; 319: 186-188.
25. Adams MR, Robinson J, Sorensen KE, Deanfield JE, Celermajer DS. Normal ranges for brachial artery flow-mediated dilatation: A non-invasive ultrasound test of arterial endothelial function. J Vasc Invest 1996, 2: 146-150.
26. Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995, 11: 1337-1344.
27. Khan F, Litchfield SJ, McLaren M, Veale DJ, Littleford RC, Belch JJF. Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthritis and Rheumatism 1997, 40: 352-357.